Literature DB >> 8699538

Group cognitive-behavioral therapy for women with PTSD and substance use disorder.

L M Najavits1, R D Weiss, B S Liese.   

Abstract

This paper describes a model of group cognitive-behavioral therapy (CBT) for women with posttraumatic stress disorder (PTSD) and substance use disorder (SUD). The need for specialized treatment derives from the high incidence of these comorbid disorders among women as well as from their particular clinical presentation and treatment needs. The treatment educates patients about the two disorders, promotes self-control skills to manage overwhelming affects, teaches functional behaviors that may have deteriorated as a result of the disorders, and provides relapse prevention training. The program draws on educational principles to make it accessible for this population: visual aids, education for the patient role, teaching for generalization, emphasis on structured treatment, testing of acquired knowledge of CBT, affectively engaging themes and materials, and memory enhancement devices.

Entities:  

Mesh:

Year:  1996        PMID: 8699538     DOI: 10.1016/0740-5472(95)02025-x

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  14 in total

Review 1.  Epidemiology and management of alcohol dependence in individuals with post-traumatic stress disorder.

Authors:  Elissa McCarthy; Ismene Petrakis
Journal:  CNS Drugs       Date:  2010-12       Impact factor: 5.749

Review 2.  Substance abuse treatment entry, retention, and outcome in women: a review of the literature.

Authors:  Shelly F Greenfield; Audrey J Brooks; Susan M Gordon; Carla A Green; Frankie Kropp; R Kathryn McHugh; Melissa Lincoln; Denise Hien; Gloria M Miele
Journal:  Drug Alcohol Depend       Date:  2006-06-08       Impact factor: 4.492

Review 3.  Concurrent Treatment of Substance Use and PTSD.

Authors:  Julianne C Flanagan; Kristina J Korte; Therese K Killeen; Sudie E Back
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

4.  A Randomized Controlled Trial Comparing Integrated Cognitive Behavioral Therapy Versus Individual Addiction Counseling for Co-occurring Substance Use and Posttraumatic Stress Disorders.

Authors:  Mark P McGovern; Chantal Lambert-Harris; Arthur I Alterman; Haiyi Xie; Andrea Meier
Journal:  J Dual Diagn       Date:  2011-01-01

5.  The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.

Authors:  Antonia N Kaczkurkin; Anu Asnaani; Elizabeth Alpert; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-02-15

6.  Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial.

Authors:  Denise A Hien; Frances Rudnick Levin; Lesia M Ruglass; Teresa López-Castro; Santiago Papini; Mei-Chen Hu; Lisa Renee Cohen; Abigail Herron
Journal:  J Consult Clin Psychol       Date:  2015-01-26

7.  Slow and steady wins the race: a randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders.

Authors:  Jason B Luoma; Barbara S Kohlenberg; Steven C Hayes; Lindsay Fletcher
Journal:  J Consult Clin Psychol       Date:  2011-10-31

8.  A preliminary examination of the relationships between posttraumatic stress symptoms and crack/cocaine, heroin, and alcohol dependence.

Authors:  Matthew T Tull; Kim L Gratz; Will M Aklin; C W Lejuez
Journal:  J Anxiety Disord       Date:  2010-01

9.  The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.

Authors:  Shelly F Greenfield; Elisa M Trucco; R Kathryn McHugh; Melissa Lincoln; Robert J Gallop
Journal:  Drug Alcohol Depend       Date:  2007-04-18       Impact factor: 4.492

10.  A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.

Authors:  Daisy J Goodman; Catherine U Milliken; Regan N Theiler; Benjamin R Nordstrom; Sarah C Akerman
Journal:  J Dual Diagn       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.